YU
Yale University Portfolio holdings
AUM
$842K
This Quarter Return
-16.51%
1 Year Return
-23.56%
3 Year Return
-46.49%
5 Year Return
-53.47%
10 Year Return
-37.45%
AUM
$324M
AUM Growth
+$324M
(-8.1%)
Cap. Flow
-$22.5M
Cap. Flow
% of AUM
-6.93%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
13
New
7
Increased
–
Reduced
1
Closed
5
Top Buys
| 1 |
JPMorgan Chase
JPM
|
$113M |
| 2 |
iShares China Large-Cap ETF
FXI
|
$109M |
| 3 |
ESMC
Escalon Medical Corp
ESMC
|
$95.9M |
| 4 |
IIN
IntriCon Corporation
IIN
|
$5.84M |
| 5 |
Atara Biotherapeutics
ATRA
|
$291K |
Top Sells
| 1 |
iShares MSCI EAFE ETF
EFA
|
$146M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$133M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$57.7M |
| 4 |
LendingClub
LC
|
$6.41M |
| 5 |
Antero Resources
AR
|
$3.09M |
Sector Composition
| 1 | Financials | 34.82% |
| 2 | Technology | 1.8% |
| 3 | Healthcare | 0.19% |
| 4 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
JPMorgan Chase
JPM
$829B
| $113M | 34.82% | +3,410,000 | New | +$113M |
|
|
2
iShares China Large-Cap ETF
FXI
$6.65B
| $109M | 33.52% | +1,895,400 | New | +$109M |
|
|
ESMC
3
DELISTED
Escalon Medical Corp
ESMC
| $95.9M | 29.59% | +2,703,700 | New | +$95.9M |
|
|
IIN
4
DELISTED
IntriCon Corporation
IIN
| $5.84M | 1.8% | +33,927 | New | +$5.84M |
|
|
5
Atara Biotherapeutics
ATRA
$84.6M
| $291K | 0.09% | +9,260 | New | +$291K |
|
6
Ironwood Pharmaceuticals
IRWD
$214M
| $250K | 0.08% | +6,238 | New | +$250K |
|
|
7
iShares MSCI EAFE ETF
EFA
$66B
| $244K | 0.08% | 4,000 -2,385,400 | -100% | -$146M |
|
8
Corcept Therapeutics
CORT
$7.35B
| $84K | 0.03% | +22,334 | New | +$84K |
|
|
9
Antero Resources
AR
$9.86B
| – | – | -90,000 | Closed | -$3.09M |
|
10
Inogen
INGN
$216M
| – | – | -8,892 | Closed | -$396K |
|
|
11
LendingClub
LC
$1.97B
| – | – | -434,566 | Closed | -$6.41M |
|
|
12
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| – | – | -3,258,000 | Closed | -$133M |
|
|
ALXN
13
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – | -319,273 | Closed | -$57.7M |
|